BLS Pharmaceuticals Limited Stock
Stocks
BLS
AU0000477796
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:15 2026-09-07 EDT
|
5-day change | 1st Jan Change | ||
| 1.100 AUD | -3.51% |
|
+19.57% | +161.90% |
| 09-01 | BLS Pharmaceuticals Limited, 2026 Earnings Call, Sep 02, 2026 | |
| 08-31 | BLS Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 | CI |
| Market Cap | 253M 183M 157M 148M 135M 253M 17.28B 1.75B 678M 8.86B 687M 672M 28.2B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 248M 179M 154M 145M 132M 248M 16.95B 1.72B 665M 8.69B 674M 659M 27.66B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
45.27% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Boerse Muenchen
| PR80 | Real-time | |
|
Deutsche Boerse AG
| PR80 | Delayed |
Last Transcript : BLS Pharmaceuticals Limited
| 1 day | -3.51% | ||
| 1 week | +19.57% | ||
| Current month | +3.77% | ||
| 1 month | +25.00% | ||
| 3 months | +27.91% | ||
| 6 months | +86.44% | ||
| Current year | +161.90% |
| 1 week | 1.06 |  | 1.2 |
| 1 month | 0.87 | | 1.2 |
| Current year | 0.36 | | 1.2 |
| 1 year | 0.33 | | 1.2 |
| 3 years | 0.04 | | 1.2 |
| 5 years | 0.04 | | 1.2 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 2023-05-18 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 2016-08-31 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 2012-12-04 |
Guy Robertson
BRD | Director/Board Member | 72 | 2022-06-29 |
Sam Watson
BRD | Director/Board Member | - | 2023-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/14/26 | Buy | 5,000,000 | 0.2202% | |||
| 5/14/26 | Exercice | 5,000,000 | 0.2202% | |||
| 3/22/26 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.51% | +19.57% | +144.44% | +547.06% | 189M | |
| -1.16% | -3.97% | -2.91% | +13.00% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| -0.96% | -2.31% | +15.75% | +45.41% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.54% | -1.05% | +12.16% | +29.80% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -1.24% | +2.82% | +81.43% | +158.26% | 27.52B | |
| Weighted average by Cap. | -1.00% | +0.07% | +89.00% | +128.73% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 21.13M 18.18M 17.1M 15.59M 29.19M 2B 203M 78.34M 1.02B 79.37M 77.63M 3.26B | 73.91M 53.35M 45.88M 43.17M 39.36M 73.68M 5.04B 512M 198M 2.59B 200M 196M 8.23B |
| Net income | 4.9M 3.54M 3.04M 2.86M 2.61M 4.89M 334M 33.93M 13.11M 171M 13.29M 12.99M 546M | 15.4M 11.11M 9.56M 8.99M 8.2M 15.35M 1.05B 107M 41.19M 539M 41.74M 40.82M 1.71B |
| Net Debt | -6.13M -4.43M -3.81M -3.58M -3.27M -6.11M -418M -42.46M -16.41M -215M -16.63M -16.26M -683M | -4.86M -3.5M -3.01M -2.84M -2.59M -4.84M -331M -33.61M -12.99M -170M -13.16M -12.87M -541M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-07 | A$1.100 | -3.51% | 267,530 |
| 26-09-04 | A$1.140 | +2.70% | 445,226 |
| 26-09-03 | A$1.110 | +0.45% | 346,819 |
| 26-09-02 | A$1.105 | -3.07% | 347,437 |
| 26-09-01 | A$1.140 | +7.55% | 1,289,037 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
